Product safety, risk assessment, and responsible care in the biocide chemical industry

Regulatory Toxicology and Pharmacology

Volumn 24, Issue 1 II, 1996, Pages 1-5

  Weiler, E D ^a   Jayjock, M A ^a   Levy, H C ^a  

^a ROHM AND HAAS COMPANY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CHEMICAL COMPOUND;

ARTICLE; CHEMICAL INDUSTRY; DRUG MANUFACTURE; DRUG TOXICITY; PRIORITY JOURNAL; RESPONSIBILITY; RISK ASSESSMENT; RISK MANAGEMENT;

BIOLOGICAL AVAILABILITY; CARCINOGENS; CHEMICAL INDUSTRY; CONSUMER PRODUCT SAFETY; DOSE-RESPONSE RELATIONSHIP, DRUG; HAZARDOUS SUBSTANCES; HUMANS; MODELS, CHEMICAL; OCCUPATIONAL HEALTH; PUBLIC HEALTH; RISK ASSESSMENT;

EID: 0029961238     PISSN: 02732300     EISSN: None     Source Type: Journal    
DOI: 10.1006/rtph.1996.0057     Document Type: Article

References (23)

1. Anderson, E. L., and Carcinogen Assessment Group of the U.S. Environmental Protection Agency (1983). Quantitative approaches in use to assess cancer risk. Risk Anal. 3, 277-295.
2. CEFIC (1995). The Responsible Care Programme is one of the chemical industry's most successful initiatives. CEFIC Spotlight, No. 35, CEFIC Communications Department, Brussels, Belgium.
3. Chemical Manufacturer's Association (CMA) (1994). Responsible Care in Action - 1993-94 Progress Report. 15M 10/94, CMA, Washington, DC.
4. Conolly, R. B. (1990). Biologically-based model for toxic effects: Tools for hypothesis testing and improving health risk assessments. CIIT Activities 10(5), 1-8.
5. Gerhardson, G. (1988). The future of occupational hygiene - An international overview. Ann. Occup. Hyg. 32(1), 1-19.
6. Hawkins, N. C. (1991). Uncertainty and Residual Risk. Presented on behalf of the Chemical Manufacturers Association to the National Research Council/National Academy of Science Committee on Risk Assessment of Hazardous Air Pollutants, November.
7. Hawkins, N. C., Jayjock, M. A., and Lynch, J. R. (1991). A rationale and framework for establishing the quality of human exposure assessments. Am. Ind. Hyg. J. 53(1), 34-41.
8. Hawkins, N. C., Laudtke, A. E., Mitchell, C. R., et al. (1992). Effects of selected process parameters on emission rates of volatile organic chemicals from carpet. Am. Ind. Hyg. Assoc. J. 53(1), 275-282.
9. IRG Secretariat (1990). Proceedings from the wood preservation symposium, The Challenge - Safety and the Environment, February 19 and 20, 1990, Cannes, France, The International Research Group on Wood Preservation, Working Group III: Preservative and Methods of Treatment, Stockholm, Sweden.
10. Jayjock, M. A., and Lewis, P. G. (1992). Low-applied-dose extrapolation of induction and elicitation of contact allergy in the evaluation and management of sensitization risk from Kathon CG isothiazolone in products. Am. J. Contact Dermatitis 3(2), 86-91.
11. Jayjock, M. A., and Hawkins, N. C. (1993). A proposal for improving the role of exposure modeling in risk assessment. Am. Ind. Hyg. J. 54(12), 733-741.
12. Jayjock, M. A., and Hawkins, N. C. (1995). Exposure database improvements for indoor air model validation. Appl. Occup. Environ. Hyg. 10(4), 379-382.
13. Jayjock, M. A. (1994). Back pressure modeling of indoor air concentration from volatilizing sources. Am. Ind. Hyg. Assoc. J. 55(3), 230-235.
14. Jayjock, M. A. (1995). Testimony before the President's Commission on Risk Assessment and Risk Management, September 14, 1995, Capitol Hill Hotel, Washington, DC.
15. Jayjock, M. A., Deepak, R. D., Nungesser, E. H., and Shade, W. D. (1995). Development and evaluation of a source/sink model of indoor air concentrations from isothiazolone treated wood used indoors. Am. Ind. Hyg. Assoc. J. 56(6), 546-557.
16. Jayjock, M. A., Hazelton, G. A., Lewis, P. G., and Wooder, M. F. (1996a). Formulation effect on the dermal bioavailability of isothiazolone biocide. Food Chem. Toxicol. 34(3), 277-282.
17. Jayjock, M. A., Reinert, K. H., Scribner, H. E., et al. (1996b). Total quality management of the risk assessment process. Am. Ind. Hyg. Assoc. J., in review.
18. Lewis, P. G., and Jayjock, M. A. (1994). Risk assessment modeling: Allergic contact dermatitis application. Am. J. Contact Dermatitis 5(3), 143-149.
19. Neal, S. B. (1990). Assessment and management of human health risk from biocides. Int. Biodeterior. 26, 259-271.
20. National Research Council (NRC). (1994). Science and Judgment in Risk Assessment. Committee on Risk Assessment of Hazardous Air Pollutants, Board on Environmental Studies and Toxicology, Commission on Life Sciences, National Academy Press, Washington, DC.
21. Ramsey, J. C., and Andersen, M. E. (1984). A physiologically based description of the inhalation pharmacokinetics of styrene in rats and humans. Toxicol. Appl. Pharmacol. 73(1), 159-175.
22. Reinert, K. H., Weiler, E. D., Fava, J. A. (1996). A new health and environmental regulatory and risk scoring index: A product stewardship and responsible care tool for improving decision-making and competitive advantage, Total Qual. Environ. Mgmt.5(3), 25-36.
23. Weiler, E. D., Jayjock, M. A., and Greenley, D. E. (1993). Quality requirements for biocides in the 1990s. Qual. Assur. Good Practice Regul. Law 2(3), 244-250.